In the clinic, PRL improves glucose homeostasis by increasing beta-cell mass under certain conditions such as pregnancy, whereas excessive high PRL levels in serum indicate a high-risk of obesity and dysmetabolism, such as decreased insulin sensitivity, abnormal glucose tolerance or progressive insulin resistance (13–17). The gene discussed is PRL; the disease is obesity due to melanocortin 4 receptor deficiency.